BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 29863189)

  • 1. Clinical significance of esophageal invasion length for the prediction of mediastinal lymph node metastasis in Siewert type II adenocarcinoma: A retrospective single-institution study.
    Koyanagi K; Kato F; Kanamori J; Daiko H; Ozawa S; Tachimori Y
    Ann Gastroenterol Surg; 2018 May; 2(3):187-196. PubMed ID: 29863189
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Accuracy of the endoscopic evaluation of esophageal involvement in esophagogastric junction cancer.
    Sakai T; Ichikawa H; Hanyu T; Usui K; Kano Y; Muneoka Y; Ishikawa T; Shimada Y; Sakata J; Wakai T
    Ann Med Surg (Lond); 2021 Aug; 68():102590. PubMed ID: 34401117
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk factor of mediastinal lymph node metastasis of Siewert type I and II esophagogastric junction carcinomas.
    Nishiwaki N; Noma K; Matsuda T; Maeda N; Tanabe S; Sakurama K; Shirakawa Y; Fujiwara T
    Langenbecks Arch Surg; 2020 Dec; 405(8):1101-1109. PubMed ID: 33155069
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Five-step maneuver of transthoracic single-port assisted laparoscopic lower mediastinal lymph node dissection for Siewert type Ⅱ adenocarcinoma of the esophagogastric junction].
    Luo SJ; Xiong WW; Chen Y; Li ZY; Li E; Zeng HP; Zheng YS; Luo LJ; Li J; Cui ZM; Wan J; Wang W
    Zhonghua Wei Chang Wai Ke Za Zhi; 2021 Aug; 24(8):684-690. PubMed ID: 34412185
    [No Abstract]   [Full Text] [Related]  

  • 5. Comparison of mediastinal lymph node metastases from adenocarcinoma of the esophagogastric junction versus lower esophageal squamous cell carcinoma with involvement of the esophagogastric junction.
    Mine S; Watanabe M; Kumagai K; Okamura A; Yuda M; Hayami M; Yamashita K; Imamura Y; Ishizuka N
    Dis Esophagus; 2019 Dec; 32(11):. PubMed ID: 30791046
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effects of robotic and laparoscopic-assisted surgery on lymph node dissection and short-term outcomes in patients with Siewert II adenocarcinoma of esophagogastric junction].
    Wang D; Cao S; Tan X; Liu S; Liu X; Niu Z; Chen D; Wang D; Zhang J; Lv L; Li Y; Jiang H; Guo D; Li Y; Li Z; Zhou Y
    Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Feb; 22(2):156-163. PubMed ID: 30799538
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mediastinal lymph node metastasis and recurrence in adenocarcinoma of the esophagogastric junction.
    Kurokawa Y; Hiki N; Yoshikawa T; Kishi K; Ito Y; Ohi M; Wada N; Takiguchi S; Mine S; Hasegawa S; Matsuda T; Takeuchi H
    Surgery; 2015 Mar; 157(3):551-5. PubMed ID: 25532434
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lymph node metastases in middle and upper mediastinum of Siewert type II adenocarcinoma: A real-world retrospective study.
    Luo P; Chen X; Yang Y; Zhang R; Kang X; Qin J; Qi X; Li Y
    Cancer Med; 2024 Feb; 13(4):e6919. PubMed ID: 38466235
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinicopathological features and prognostic factors of adenocarcinoma of the esophagogastric junction according to Siewert classification: experiences at a single institution in Japan.
    Hosokawa Y; Kinoshita T; Konishi M; Takahashi S; Gotohda N; Kato Y; Daiko H; Nishimura M; Katsumata K; Sugiyama Y; Kinoshita T
    Ann Surg Oncol; 2012 Feb; 19(2):677-83. PubMed ID: 21822549
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mediastinal Nodal Involvement After Neoadjuvant Chemoradiation for Siewert II/III Adenocarcinoma.
    Mitchell KG; Ikoma N; Nelson DB; Maru DM; Erasmus JJ; Weston BR; Vaporciyan AA; Antonoff MB; Mehran RJ; Rice DC; Roth JA; Swisher SG; Sepesi B; Walsh GL; Correa AM; Das P; Blum MA; Badgwell BD; Hofstetter WL
    Ann Thorac Surg; 2019 Sep; 108(3):845-851. PubMed ID: 31102632
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Assessment of risk factors of lymph node metastasis and prognosis of Siewert II/III adenocarcinoma of esophagogastric junction: A retrospective study.
    Huang Y; Zheng Z; Xu R; Zhang H; Yin J; Liu X; Zhang J; Chen G; Zhang Z
    Medicine (Baltimore); 2024 Mar; 103(9):e37289. PubMed ID: 38428860
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Distribution of lymph node metastases in locally advanced adenocarcinomas of the esophagogastric junction (cT2-4): comparison between Siewert type I and selected Siewert type II tumors.
    Sakaki A; Kanamori J; Ishiyama K; Kurita D; Oguma J; Daiko H
    Langenbecks Arch Surg; 2020 Jun; 405(4):509-519. PubMed ID: 32514766
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical significance of lower perigastric lymph nodes dissection in Siewert type II/III adenocarcinoma of esophagogastric junction: a retrospective propensity score matched study.
    Li ZL; Zhao LY; Zhang WH; Liu K; Pang HY; Chen XL; Chen XZ; Yang K; Hu JK
    Langenbecks Arch Surg; 2022 May; 407(3):985-998. PubMed ID: 34792614
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Patterns of the lymph node metastasis and the influencing factors in esophagogastric junction cancers.
    Zhang D; Nan Q
    Asian J Surg; 2023 Sep; 46(9):3512-3519. PubMed ID: 37670436
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Survival comparison of Siewert II adenocarcinoma of esophagogastric junction between transthoracic and transabdominal approaches:a joint data analysis of thoracic and gastrointestinal surgery].
    Yang S; Yuan Y; Hu H; Li R; Liu K; Zhang W; Yang K; Yang Y; Bai D; Chen X; Zhou Z; Chen L
    Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Feb; 22(2):132-142. PubMed ID: 30799535
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Patterns and influencing factors of lymph node metastasis of adenocarcinoma of the esophagogastric junction in 393 patients].
    Zhang YJ; Wang J; Zhang XL; Liu Q; Jing SW; Wang Y; Cao F; Jiao WP
    Zhonghua Zhong Liu Za Zhi; 2016 Sep; 38(9):672-6. PubMed ID: 27647399
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinicopathological Characteristics and Prognostic Factors of Patients with Siewert Type II Esophagogastric Junction Carcinoma: A Retrospective Multicenter Study.
    Matsuda T; Kurokawa Y; Yoshikawa T; Kishi K; Misawa K; Ohi M; Mine S; Hiki N; Takeuchi H
    World J Surg; 2016 Jul; 40(7):1672-9. PubMed ID: 26928855
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Incidence of lymph node metastasis at each station in Siewert types Ⅱ/Ⅲ adenocarcinoma of the esophagogastric junction: A systematic review and meta-analysis.
    Chen XD; He FQ; Chen M; Zhao FZ
    Surg Oncol; 2020 Dec; 35():62-70. PubMed ID: 32835903
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lower mediastinal lymph node metastasis is an independent survival factor of Siewert type II and III adenocarcinomas in the gastroesophageal junction.
    Nakamura M; Iwahashi M; Nakamori M; Naka T; Ojima T; Iida T; Katsuda M; Tsuji T; Hayata K; Mastumura S; Yamaue H
    Am Surg; 2012 May; 78(5):567-73. PubMed ID: 22546130
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The prognostic relevance of parapyloric lymph node metastasis in Siewert type II/III adenocarcinoma of the esophagogastric junction.
    Wang JB; Lin MQ; Li P; Xie JW; Lin JX; Lu J; Chen QY; Cao LL; Lin M; Zheng CH; Huang CM
    Eur J Surg Oncol; 2017 Dec; 43(12):2333-2340. PubMed ID: 28928013
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.